News

In 2021, a University-led research team received a contract worth up to $33 million to develop an implantable “living pharmacy” to control the human body’s sleep/wake cycles. Now, the researchers have completed a major step toward achieving this.

Precision treatment for rheumatoid arthritis is key. New research has used a cellular atlas to outline the variety of cellular causes, which may inform targeted, effective therapies.

While we all aspire for a long lifespan, what is most coveted is a long period of vigor and health, or “healthspan,” that precedes the inevitable decline of advancing age.

Recent studies indicate that inflammation is one of the causes of the development of benign prostatic hyperplasia (BPH). Inflammation may result from past infections, but also from the state of functioning of the intestinal microbiota.

A human tissue model of a bladder has been used by researchers to show that bacterial strains can hide in the bladder wall, causing persistent urinary tract infections.

A study analzyes the genetics of 275 human lice, revealing new clues about human migration.

The Synthetic Yeast Genome Project 2.0 declares a major milestone: it has created a yeast strain comprising over 50% synthetic DNA.

The genetic "ringleader" behind a molecular domino effect driving prostate cancer growth and metastasis has been identified in new research.

Using a technique that has shown promise in targeting cancer tumors, a Duke Health team has found a way to deploy a molecular warhead that can annihilate the bacterium that causes Lyme disease.

An international team of researchers has discovered that formaldehyde, a widely spread pollutant and common metabolite in our body, interferes in the epigenetic programming of the cell.